<?xml version="1.0" encoding="UTF-8"?>
<ref id="B149-vaccines-08-00224">
 <label>149.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Khalili</surname>
    <given-names>J.S.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Mak</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Yan</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>Novel coronavirus treatment with ribavirin: Groundwork for evaluation concerning COVID-19</article-title>
  <source>J. Med. Virol.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1002/jmv.25798</pub-id>
  <?supplied-pmid 32227493?>
  <pub-id pub-id-type="pmid">32227493</pub-id>
 </element-citation>
</ref>
